Tissue Repair · Research Blend
BB (BPC-157 & TB-500)
A two-peptide research blend of BPC-157 and TB-500 — the pairing known in research circles as the "Wolverine" stack — studied in preclinical tissue-repair models.
BB is a two-peptide research blend combining BPC-157 and TB-500 (10mg each) in a single vial. The pairing is so common in tissue-repair research that it has earned its own community nickname — the “Wolverine” stack — a nod to how frequently the two peptides appear together in preclinical studies of healing and regeneration models.
The two are mechanistically complementary, which is exactly why they are co-studied: BPC-157, a stable synthetic peptide derived from a protective gastric protein, is investigated for cytoprotective and tissue-repair signaling, while TB-500, a synthetic fragment of Thymosin Beta-4, is investigated for actin-mediated cell migration and blood-vessel formation. Repair models depend on both signaling and cell movement, making the combination a natural research design. As with the individual compounds, the evidence base is entirely preclinical — cell-culture and animal models — with no human trials of the blend.
Research areas
Tendon & Ligament Models
The most active shared territory: both peptides have independent rodent-model literature on tendon-to-bone healing, fibroblast migration, and soft-tissue repair.
Wound-Healing Models
Studied for complementary effects — repair signaling (BPC-157) alongside accelerated cell migration and re-epithelialization (Tβ4 fragments).
Angiogenesis Research
Both components have documented pro-angiogenic activity in preclinical models — VEGFR2-pathway signaling for BPC-157 and Tβ4-driven vessel formation.
Inflammation Signaling
Each peptide is separately investigated for modulation of inflammatory pathways during tissue repair.
Recent research findings
- 2024Preclinical work on both components continued — nitric-oxide and growth-factor signaling for BPC-157, and Ac-SDKP fragment vascular signaling for Tβ4.
- 2023Reviews of each compound catalogued the breadth of rodent-model repair evidence while noting the absence of human trials.
- 2022Co-use of the two peptides in tissue-repair study designs became common enough that the "Wolverine" pairing entered mainstream research-community vocabulary.
Published Research & Citations
The research summarized above is drawn from published, peer-reviewed studies. Explore the 6 sources below — links open the abstract or, where marked, the full free article on the U.S. National Library of Medicine (PubMed / PMC).
- Seiwerth S, et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Frontiers in Pharmacology, 2021. Free full text Open-access review of BPC 157 across skin wounds, burns, and rodent healing models.
- Gwyer D, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 2019. Review of soft-tissue (tendon, ligament, muscle) repair evidence and proposed mechanisms.
- Xing Y, et al. Progress on the Function and Application of Thymosin β4. Frontiers in Endocrinology, 2021. Free full text Open-access review of Tβ4's roles in actin regulation, angiogenesis, and tissue regeneration.
- Goldstein AL, et al. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine, 2005. Foundational review establishing Tβ4 as the major actin-sequestering molecule with tissue-repair roles.
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 1999. Rat full-thickness wound model; faster re-epithelialization vs. controls.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011. In vitro study showing increased tendon fibroblast outgrowth, survival, and migration.